BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30967633)

  • 1. NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer.
    Zhou P; Li Y; Li B; Zhang M; Liu Y; Yao Y; Li D
    Oncogene; 2019 Jul; 38(27):5500-5515. PubMed ID: 30967633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling.
    Li TH; Zhao BB; Qin C; Wang YY; Li ZR; Cao HT; Yang XY; Zhou XT; Wang WB
    Cell Oncol (Dordr); 2021 Dec; 44(6):1425-1437. PubMed ID: 34791638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
    Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis
    Peng X; Yang R; Song J; Wang X; Dong W
    Front Med (Lausanne); 2022; 9():783592. PubMed ID: 35707527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway.
    Liu SL; Cai C; Yang ZY; Wu ZY; Wu XS; Wang XF; Dong P; Gong W
    Int J Biol Sci; 2021; 17(2):498-513. PubMed ID: 33613108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
    Li F; Dai L; Niu J
    J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling.
    Shao M; Wang L; Zhang Q; Wang T; Wang S
    Cancer Gene Ther; 2023 Mar; 30(3):472-480. PubMed ID: 36460804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis through Wnt/β-catenin-Mediated EMT.
    Liu F; Xia Z; Zhang M; Ding J; Feng Y; Wu J; Dong Y; Gao W; Han Z; Liu Y; Yao Y; Li D
    Int J Biol Sci; 2019; 15(3):636-646. PubMed ID: 30745850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling.
    Qian Y; Li J; Xia S
    Dig Dis Sci; 2017 Aug; 62(8):2011-2020. PubMed ID: 28523575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
    Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
    J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
    Pai P; Rachagani S; Lakshmanan I; Macha MA; Sheinin Y; Smith LM; Ponnusamy MP; Batra SK
    Mol Oncol; 2016 Feb; 10(2):224-39. PubMed ID: 26526617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger protein 91 accelerates tumour progression by activating β-catenin signalling in pancreatic cancer.
    Tang N; Xu S; Song T; Qiu Y; He J; Fu X
    Cell Prolif; 2021 May; 54(5):e13031. PubMed ID: 33755268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.